These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18401779)

  • 1. A novel superdisintegrating agent made from physically modified chitosan with silicon dioxide.
    El-Barghouthi M; Eftaiha A; Rashid I; Al-Remawi M; Badwan A
    Drug Dev Ind Pharm; 2008 Apr; 34(4):373-83. PubMed ID: 18401779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitin-silicon dioxide coprecipitate as a novel superdisintegrant.
    Rashid I; Al-Remawi M; Eftaiha A; Badwan A
    J Pharm Sci; 2008 Nov; 97(11):4955-69. PubMed ID: 18314884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginates as tablet disintegrants: Understanding disintegration mechanisms and defining ranges of applications.
    Berardi A; Bauhuber S; Sawafta O; Warnke G
    Int J Pharm; 2021 May; 601():120512. PubMed ID: 33766641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of compacted hydrophobic and hydrophilic colloidal silicon dioxide on tableting properties of pharmaceutical excipients.
    Jonat S; Hasenzahl S; Gray A; Schmidt PC
    Drug Dev Ind Pharm; 2005 Aug; 31(7):687-96. PubMed ID: 16207616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
    Bresolin JR; Largura MC; Dalri CC; Hoffer G; Rodrigues CA; Lucinda-Silva RM
    Drug Dev Ind Pharm; 2014 Apr; 40(4):503-10. PubMed ID: 23594298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
    Chaheen M; Soulairol I; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2017 Jul; 106(7):1839-1848. PubMed ID: 28392454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
    Goel H; Tiwary AK; Rana V
    Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superdisintegrants used in pharmaceutical technology.
    Gajdziok J
    Ceska Slov Farm; 2018; 67(2):59-65. PubMed ID: 30189734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
    Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
    Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1983 Aug; 5(4):165-71. PubMed ID: 6622211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excipient-process interactions and their impact on tablet compaction and film coating.
    Pandey P; Bindra DS; Gour S; Trinh J; Buckley D; Badawy S
    J Pharm Sci; 2014 Nov; 103(11):3666-3674. PubMed ID: 25223603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Disintegrants and the Disintegration Phenomena.
    Desai PM; Liew CV; Heng PWS
    J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.